Impact of Induction Therapy on Delayed Graft Function Following Kidney Transplantation in Mated Kidneys

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background Delayed graft function (DGF) is defined as the need for dialysis within 1 week of transplantation and occurs in 20%–50% of deceased-donor kidney transplant recipients. Although recovery from DGF often occurs within a few days, many cases may take weeks to months before the transplant function begins. The delay in function increases the complexity of recipient care, makes the diagnosis of acute rejection more difficult, prolongs length of stay, and increases hospital costs. Although several authors have proposed nomograms to predict DGF, there is no identifiable strategy to ameliorate it, except for the possible use of a specific type of induction therapy called Thymoglobulin. Methods In this retrospective analysis we included 407 subjects, of which 76 were mated (left and right kidney transplanted at Montefiore from the same donor). We used conditional logistic regression analysis while adjusting for the mated kidneys. We adjusted for age, gender, and race a priori, as well as cold ischemia time. Results There was a 36% decrease in odds of DGF when Thymoglobulin was used as induction when compared with basiliximab in mated kidneys 0.64 (0.10–4.05) (odds ratio [OR] with 95% confidence interval [CI]). Conclusions Thymoglobulin did have a protective effect in these data when analyzed in mated kidneys, however, we need a larger amount of data to concretely conclude this effect.

Original languageEnglish (US)
Pages (from-to)1739-1742
Number of pages4
JournalTransplantation Proceedings
Volume49
Issue number8
DOIs
StatePublished - Oct 1 2017

Fingerprint

Delayed Graft Function
Kidney Transplantation
Kidney
Tissue Donors
Therapeutics
Cold Ischemia
Nomograms
Hospital Costs
Dialysis
Length of Stay
Transplantation
Logistic Models
Odds Ratio
Regression Analysis
Confidence Intervals
Transplants
thymoglobulin

ASJC Scopus subject areas

  • Surgery
  • Transplantation

Cite this

Impact of Induction Therapy on Delayed Graft Function Following Kidney Transplantation in Mated Kidneys. / Butler, T.; Hayde, Nicole A.M.

In: Transplantation Proceedings, Vol. 49, No. 8, 01.10.2017, p. 1739-1742.

Research output: Contribution to journalArticle

@article{6cb168f491c14c0d9d470c94c457e3c6,
title = "Impact of Induction Therapy on Delayed Graft Function Following Kidney Transplantation in Mated Kidneys",
abstract = "Background Delayed graft function (DGF) is defined as the need for dialysis within 1 week of transplantation and occurs in 20{\%}–50{\%} of deceased-donor kidney transplant recipients. Although recovery from DGF often occurs within a few days, many cases may take weeks to months before the transplant function begins. The delay in function increases the complexity of recipient care, makes the diagnosis of acute rejection more difficult, prolongs length of stay, and increases hospital costs. Although several authors have proposed nomograms to predict DGF, there is no identifiable strategy to ameliorate it, except for the possible use of a specific type of induction therapy called Thymoglobulin. Methods In this retrospective analysis we included 407 subjects, of which 76 were mated (left and right kidney transplanted at Montefiore from the same donor). We used conditional logistic regression analysis while adjusting for the mated kidneys. We adjusted for age, gender, and race a priori, as well as cold ischemia time. Results There was a 36{\%} decrease in odds of DGF when Thymoglobulin was used as induction when compared with basiliximab in mated kidneys 0.64 (0.10–4.05) (odds ratio [OR] with 95{\%} confidence interval [CI]). Conclusions Thymoglobulin did have a protective effect in these data when analyzed in mated kidneys, however, we need a larger amount of data to concretely conclude this effect.",
author = "T. Butler and Hayde, {Nicole A.M.}",
year = "2017",
month = "10",
day = "1",
doi = "10.1016/j.transproceed.2017.06.032",
language = "English (US)",
volume = "49",
pages = "1739--1742",
journal = "Transplantation Proceedings",
issn = "0041-1345",
publisher = "Elsevier USA",
number = "8",

}

TY - JOUR

T1 - Impact of Induction Therapy on Delayed Graft Function Following Kidney Transplantation in Mated Kidneys

AU - Butler, T.

AU - Hayde, Nicole A.M.

PY - 2017/10/1

Y1 - 2017/10/1

N2 - Background Delayed graft function (DGF) is defined as the need for dialysis within 1 week of transplantation and occurs in 20%–50% of deceased-donor kidney transplant recipients. Although recovery from DGF often occurs within a few days, many cases may take weeks to months before the transplant function begins. The delay in function increases the complexity of recipient care, makes the diagnosis of acute rejection more difficult, prolongs length of stay, and increases hospital costs. Although several authors have proposed nomograms to predict DGF, there is no identifiable strategy to ameliorate it, except for the possible use of a specific type of induction therapy called Thymoglobulin. Methods In this retrospective analysis we included 407 subjects, of which 76 were mated (left and right kidney transplanted at Montefiore from the same donor). We used conditional logistic regression analysis while adjusting for the mated kidneys. We adjusted for age, gender, and race a priori, as well as cold ischemia time. Results There was a 36% decrease in odds of DGF when Thymoglobulin was used as induction when compared with basiliximab in mated kidneys 0.64 (0.10–4.05) (odds ratio [OR] with 95% confidence interval [CI]). Conclusions Thymoglobulin did have a protective effect in these data when analyzed in mated kidneys, however, we need a larger amount of data to concretely conclude this effect.

AB - Background Delayed graft function (DGF) is defined as the need for dialysis within 1 week of transplantation and occurs in 20%–50% of deceased-donor kidney transplant recipients. Although recovery from DGF often occurs within a few days, many cases may take weeks to months before the transplant function begins. The delay in function increases the complexity of recipient care, makes the diagnosis of acute rejection more difficult, prolongs length of stay, and increases hospital costs. Although several authors have proposed nomograms to predict DGF, there is no identifiable strategy to ameliorate it, except for the possible use of a specific type of induction therapy called Thymoglobulin. Methods In this retrospective analysis we included 407 subjects, of which 76 were mated (left and right kidney transplanted at Montefiore from the same donor). We used conditional logistic regression analysis while adjusting for the mated kidneys. We adjusted for age, gender, and race a priori, as well as cold ischemia time. Results There was a 36% decrease in odds of DGF when Thymoglobulin was used as induction when compared with basiliximab in mated kidneys 0.64 (0.10–4.05) (odds ratio [OR] with 95% confidence interval [CI]). Conclusions Thymoglobulin did have a protective effect in these data when analyzed in mated kidneys, however, we need a larger amount of data to concretely conclude this effect.

UR - http://www.scopus.com/inward/record.url?scp=85031718281&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85031718281&partnerID=8YFLogxK

U2 - 10.1016/j.transproceed.2017.06.032

DO - 10.1016/j.transproceed.2017.06.032

M3 - Article

VL - 49

SP - 1739

EP - 1742

JO - Transplantation Proceedings

JF - Transplantation Proceedings

SN - 0041-1345

IS - 8

ER -